 | • レポートコード：MRC2-11QY06722 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は胃腸OTC薬のグローバル市場について調査・分析したレポートです。種類別（下剤、抗鼓腸薬、H2-拮抗薬、止瀉薬、PPI、制吐薬、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別胃腸OTC薬の競争状況、市場シェア ・世界の胃腸OTC薬市場：種類別市場規模 2015年-2020年（下剤、抗鼓腸薬、H2-拮抗薬、止瀉薬、PPI、制吐薬、その他） ・世界の胃腸OTC薬市場：種類別市場規模予測 2021年-2026年（下剤、抗鼓腸薬、H2-拮抗薬、止瀉薬、PPI、制吐薬、その他） ・世界の胃腸OTC薬市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局） ・世界の胃腸OTC薬市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局） ・北米の胃腸OTC薬市場分析：米国、カナダ ・ヨーロッパの胃腸OTC薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの胃腸OTC薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の胃腸OTC薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの胃腸OTC薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GlaxoSmithKline、Pfizer、Johnson & Johnson、Bayer、Procter & Gamble、Perrigo、Abbott、Sanofi、Teva Pharmaceutical、Nestle、Boehringer Ingelheim、Reckitt Benckiser、Purdue Pharma ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Gastrointestinal OTC drugs are used for indications such as GERD, vomiting, constipation, diarrhea, and flatulence. Some of the OTC drugs that are available for the treatment of gastrointestinal diseases are laxatives, anti-flatulents, H2-antaginists, anti-diarrheals, PPIs, and anti-emetics. The OTC drugs are not bound by regulatory guidelines, but need to comply with the drug monograph of a country.
Market Analysis and Insights: Global Gastrointestinal OTC Drugs Market
The global Gastrointestinal OTC Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Gastrointestinal OTC Drugs Scope and Market Size
Gastrointestinal OTC Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Gastrointestinal OTC Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Gastrointestinal OTC Drugs market is segmented into
Laxatives
Anti-Flatulents
H2-Antaginists
Anti-Diarrheals
PPIs
Anti-Emetics
Other
Segment by Application, the Gastrointestinal OTC Drugs market is segmented into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional and Country-level Analysis
The Gastrointestinal OTC Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Gastrointestinal OTC Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Gastrointestinal OTC Drugs Market Share Analysis
Gastrointestinal OTC Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Gastrointestinal OTC Drugs business, the date to enter into the Gastrointestinal OTC Drugs market, Gastrointestinal OTC Drugs product introduction, recent developments, etc.
The major vendors covered:
GlaxoSmithKline
Pfizer
Johnson & Johnson
Bayer
Procter & Gamble
Perrigo
Abbott
Sanofi
Teva Pharmaceutical
Nestle
Boehringer Ingelheim
Reckitt Benckiser
Purdue Pharma
1 Study Coverage
1.1 Gastrointestinal OTC Drugs Product Introduction
1.2 Market Segments
1.3 Key Gastrointestinal OTC Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Gastrointestinal OTC Drugs Market Size Growth Rate by Type
1.4.2 Laxatives
1.4.3 Anti-Flatulents
1.4.4 H2-Antaginists
1.4.5 Anti-Diarrheals
1.4.6 PPIs
1.4.7 Anti-Emetics
1.4.8 Other
1.5 Market by Application
1.5.1 Global Gastrointestinal OTC Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Gastrointestinal OTC Drugs Market Size, Estimates and Forecasts
2.1.1 Global Gastrointestinal OTC Drugs Revenue 2015-2026
2.1.2 Global Gastrointestinal OTC Drugs Sales 2015-2026
2.2 Global Gastrointestinal OTC Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Gastrointestinal OTC Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Gastrointestinal OTC Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Gastrointestinal OTC Drugs Competitor Landscape by Players
3.1 Gastrointestinal OTC Drugs Sales by Manufacturers
3.1.1 Gastrointestinal OTC Drugs Sales by Manufacturers (2015-2020)
3.1.2 Gastrointestinal OTC Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Gastrointestinal OTC Drugs Revenue by Manufacturers
3.2.1 Gastrointestinal OTC Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Gastrointestinal OTC Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Gastrointestinal OTC Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Gastrointestinal OTC Drugs Revenue in 2019
3.2.5 Global Gastrointestinal OTC Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Gastrointestinal OTC Drugs Price by Manufacturers
3.4 Gastrointestinal OTC Drugs Manufacturing Base Distribution, Product Types
3.4.1 Gastrointestinal OTC Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Gastrointestinal OTC Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Gastrointestinal OTC Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Gastrointestinal OTC Drugs Market Size by Type (2015-2020)
4.1.1 Global Gastrointestinal OTC Drugs Sales by Type (2015-2020)
4.1.2 Global Gastrointestinal OTC Drugs Revenue by Type (2015-2020)
4.1.3 Gastrointestinal OTC Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Gastrointestinal OTC Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Gastrointestinal OTC Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Gastrointestinal OTC Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Gastrointestinal OTC Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Gastrointestinal OTC Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Gastrointestinal OTC Drugs Market Size by Application (2015-2020)
5.1.1 Global Gastrointestinal OTC Drugs Sales by Application (2015-2020)
5.1.2 Global Gastrointestinal OTC Drugs Revenue by Application (2015-2020)
5.1.3 Gastrointestinal OTC Drugs Price by Application (2015-2020)
5.2 Gastrointestinal OTC Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Gastrointestinal OTC Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Gastrointestinal OTC Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Gastrointestinal OTC Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Gastrointestinal OTC Drugs by Country
6.1.1 North America Gastrointestinal OTC Drugs Sales by Country
6.1.2 North America Gastrointestinal OTC Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Gastrointestinal OTC Drugs Market Facts & Figures by Type
6.3 North America Gastrointestinal OTC Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Gastrointestinal OTC Drugs by Country
7.1.1 Europe Gastrointestinal OTC Drugs Sales by Country
7.1.2 Europe Gastrointestinal OTC Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Gastrointestinal OTC Drugs Market Facts & Figures by Type
7.3 Europe Gastrointestinal OTC Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Gastrointestinal OTC Drugs by Region
8.1.1 Asia Pacific Gastrointestinal OTC Drugs Sales by Region
8.1.2 Asia Pacific Gastrointestinal OTC Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Gastrointestinal OTC Drugs Market Facts & Figures by Type
8.3 Asia Pacific Gastrointestinal OTC Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Gastrointestinal OTC Drugs by Country
9.1.1 Latin America Gastrointestinal OTC Drugs Sales by Country
9.1.2 Latin America Gastrointestinal OTC Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Gastrointestinal OTC Drugs Market Facts & Figures by Type
9.3 Central & South America Gastrointestinal OTC Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Gastrointestinal OTC Drugs by Country
10.1.1 Middle East and Africa Gastrointestinal OTC Drugs Sales by Country
10.1.2 Middle East and Africa Gastrointestinal OTC Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Gastrointestinal OTC Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Gastrointestinal OTC Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Gastrointestinal OTC Drugs Products Offered
11.1.5 GlaxoSmithKline Related Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Description and Business Overview
11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pfizer Gastrointestinal OTC Drugs Products Offered
11.2.5 Pfizer Related Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Description and Business Overview
11.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Johnson & Johnson Gastrointestinal OTC Drugs Products Offered
11.3.5 Johnson & Johnson Related Developments
11.4 Bayer
11.4.1 Bayer Corporation Information
11.4.2 Bayer Description and Business Overview
11.4.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bayer Gastrointestinal OTC Drugs Products Offered
11.4.5 Bayer Related Developments
11.5 Procter & Gamble
11.5.1 Procter & Gamble Corporation Information
11.5.2 Procter & Gamble Description and Business Overview
11.5.3 Procter & Gamble Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Procter & Gamble Gastrointestinal OTC Drugs Products Offered
11.5.5 Procter & Gamble Related Developments
11.6 Perrigo
11.6.1 Perrigo Corporation Information
11.6.2 Perrigo Description and Business Overview
11.6.3 Perrigo Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Perrigo Gastrointestinal OTC Drugs Products Offered
11.6.5 Perrigo Related Developments
11.7 Abbott
11.7.1 Abbott Corporation Information
11.7.2 Abbott Description and Business Overview
11.7.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Abbott Gastrointestinal OTC Drugs Products Offered
11.7.5 Abbott Related Developments
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Description and Business Overview
11.8.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sanofi Gastrointestinal OTC Drugs Products Offered
11.8.5 Sanofi Related Developments
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Corporation Information
11.9.2 Teva Pharmaceutical Description and Business Overview
11.9.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Teva Pharmaceutical Gastrointestinal OTC Drugs Products Offered
11.9.5 Teva Pharmaceutical Related Developments
11.10 Nestle
11.10.1 Nestle Corporation Information
11.10.2 Nestle Description and Business Overview
11.10.3 Nestle Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Nestle Gastrointestinal OTC Drugs Products Offered
11.10.5 Nestle Related Developments
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Description and Business Overview
11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GlaxoSmithKline Gastrointestinal OTC Drugs Products Offered
11.1.5 GlaxoSmithKline Related Developments
11.12 Reckitt Benckiser
11.12.1 Reckitt Benckiser Corporation Information
11.12.2 Reckitt Benckiser Description and Business Overview
11.12.3 Reckitt Benckiser Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Reckitt Benckiser Products Offered
11.12.5 Reckitt Benckiser Related Developments
11.13 Purdue Pharma
11.13.1 Purdue Pharma Corporation Information
11.13.2 Purdue Pharma Description and Business Overview
11.13.3 Purdue Pharma Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Purdue Pharma Products Offered
11.13.5 Purdue Pharma Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Gastrointestinal OTC Drugs Market Estimates and Projections by Region
12.1.1 Global Gastrointestinal OTC Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Gastrointestinal OTC Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Gastrointestinal OTC Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Gastrointestinal OTC Drugs Sales Forecast (2021-2026)
12.2.2 North America: Gastrointestinal OTC Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Gastrointestinal OTC Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Gastrointestinal OTC Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Gastrointestinal OTC Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Gastrointestinal OTC Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Gastrointestinal OTC Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Gastrointestinal OTC Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Gastrointestinal OTC Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Gastrointestinal OTC Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Gastrointestinal OTC Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Gastrointestinal OTC Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Gastrointestinal OTC Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Gastrointestinal OTC Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Gastrointestinal OTC Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Gastrointestinal OTC Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Gastrointestinal OTC Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Gastrointestinal OTC Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Gastrointestinal OTC Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Gastrointestinal OTC Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Gastrointestinal OTC Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Gastrointestinal OTC Drugs Market Segments
Table 2. Ranking of Global Top Gastrointestinal OTC Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Gastrointestinal OTC Drugs Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Laxatives
Table 5. Major Manufacturers of Anti-Flatulents
Table 6. Major Manufacturers of H2-Antaginists
Table 7. Major Manufacturers of Anti-Diarrheals
Table 8. Major Manufacturers of PPIs
Table 9. Major Manufacturers of Anti-Emetics
Table 10. Major Manufacturers of Other
Table 11. Global Gastrointestinal OTC Drugs Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 12. Global Gastrointestinal OTC Drugs Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 13. Global Gastrointestinal OTC Drugs Sales by Regions 2015-2020 (K Pcs)
Table 14. Global Gastrointestinal OTC Drugs Sales Market Share by Regions (2015-2020)
Table 15. Global Gastrointestinal OTC Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Gastrointestinal OTC Drugs Sales by Manufacturers (2015-2020) (K Pcs)
Table 17. Global Gastrointestinal OTC Drugs Sales Share by Manufacturers (2015-2020)
Table 18. Global Gastrointestinal OTC Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Gastrointestinal OTC Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal OTC Drugs as of 2019)
Table 20. Gastrointestinal OTC Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Gastrointestinal OTC Drugs Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Gastrointestinal OTC Drugs Price (2015-2020) (USD/Pcs)
Table 23. Gastrointestinal OTC Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Gastrointestinal OTC Drugs Product Type
Table 25. Date of International Manufacturers Enter into Gastrointestinal OTC Drugs Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Gastrointestinal OTC Drugs Sales by Type (2015-2020) (K Pcs)
Table 28. Global Gastrointestinal OTC Drugs Sales Share by Type (2015-2020)
Table 29. Global Gastrointestinal OTC Drugs Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Gastrointestinal OTC Drugs Revenue Share by Type (2015-2020)
Table 31. Gastrointestinal OTC Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 32. Global Gastrointestinal OTC Drugs Sales by Application (2015-2020) (K Pcs)
Table 33. Global Gastrointestinal OTC Drugs Sales Share by Application (2015-2020)
Table 34. North America Gastrointestinal OTC Drugs Sales by Country (2015-2020) (K Pcs)
Table 35. North America Gastrointestinal OTC Drugs Sales Market Share by Country (2015-2020)
Table 36. North America Gastrointestinal OTC Drugs Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Gastrointestinal OTC Drugs Revenue Market Share by Country (2015-2020)
Table 38. North America Gastrointestinal OTC Drugs Sales by Type (2015-2020) (K Pcs)
Table 39. North America Gastrointestinal OTC Drugs Sales Market Share by Type (2015-2020)
Table 40. North America Gastrointestinal OTC Drugs Sales by Application (2015-2020) (K Pcs)
Table 41. North America Gastrointestinal OTC Drugs Sales Market Share by Application (2015-2020)
Table 42. Europe Gastrointestinal OTC Drugs Sales by Country (2015-2020) (K Pcs)
Table 43. Europe Gastrointestinal OTC Drugs Sales Market Share by Country (2015-2020)
Table 44. Europe Gastrointestinal OTC Drugs Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Gastrointestinal OTC Drugs Revenue Market Share by Country (2015-2020)
Table 46. Europe Gastrointestinal OTC Drugs Sales by Type (2015-2020) (K Pcs)
Table 47. Europe Gastrointestinal OTC Drugs Sales Market Share by Type (2015-2020)
Table 48. Europe Gastrointestinal OTC Drugs Sales by Application (2015-2020) (K Pcs)
Table 49. Europe Gastrointestinal OTC Drugs Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Gastrointestinal OTC Drugs Sales by Region (2015-2020) (K Pcs)
Table 51. Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Gastrointestinal OTC Drugs Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Gastrointestinal OTC Drugs Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Gastrointestinal OTC Drugs Sales by Type (2015-2020) (K Pcs)
Table 55. Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Gastrointestinal OTC Drugs Sales by Application (2015-2020) (K Pcs)
Table 57. Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Application (2015-2020)
Table 58. Latin America Gastrointestinal OTC Drugs Sales by Country (2015-2020) (K Pcs)
Table 59. Latin America Gastrointestinal OTC Drugs Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Gastrointestinal OTC Drugs Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Gastrointestinal OTC Drugs Revenue Market Share by Country (2015-2020)
Table 62. Latin America Gastrointestinal OTC Drugs Sales by Type (2015-2020) (K Pcs)
Table 63. Latin America Gastrointestinal OTC Drugs Sales Market Share by Type (2015-2020)
Table 64. Latin America Gastrointestinal OTC Drugs Sales by Application (2015-2020) (K Pcs)
Table 65. Latin America Gastrointestinal OTC Drugs Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Gastrointestinal OTC Drugs Sales by Country (2015-2020) (K Pcs)
Table 67. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Gastrointestinal OTC Drugs Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Gastrointestinal OTC Drugs Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Gastrointestinal OTC Drugs Sales by Type (2015-2020) (K Pcs)
Table 71. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Gastrointestinal OTC Drugs Sales by Application (2015-2020) (K Pcs)
Table 73. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Application (2015-2020)
Table 74. GlaxoSmithKline Corporation Information
Table 75. GlaxoSmithKline Description and Major Businesses
Table 76. GlaxoSmithKline Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 77. GlaxoSmithKline Product
Table 78. GlaxoSmithKline Recent Development
Table 79. Pfizer Corporation Information
Table 80. Pfizer Description and Major Businesses
Table 81. Pfizer Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 82. Pfizer Product
Table 83. Pfizer Recent Development
Table 84. Johnson & Johnson Corporation Information
Table 85. Johnson & Johnson Description and Major Businesses
Table 86. Johnson & Johnson Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 87. Johnson & Johnson Product
Table 88. Johnson & Johnson Recent Development
Table 89. Bayer Corporation Information
Table 90. Bayer Description and Major Businesses
Table 91. Bayer Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 92. Bayer Product
Table 93. Bayer Recent Development
Table 94. Procter & Gamble Corporation Information
Table 95. Procter & Gamble Description and Major Businesses
Table 96. Procter & Gamble Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 97. Procter & Gamble Product
Table 98. Procter & Gamble Recent Development
Table 99. Perrigo Corporation Information
Table 100. Perrigo Description and Major Businesses
Table 101. Perrigo Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 102. Perrigo Product
Table 103. Perrigo Recent Development
Table 104. Abbott Corporation Information
Table 105. Abbott Description and Major Businesses
Table 106. Abbott Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 107. Abbott Product
Table 108. Abbott Recent Development
Table 109. Sanofi Corporation Information
Table 110. Sanofi Description and Major Businesses
Table 111. Sanofi Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Sanofi Product
Table 113. Sanofi Recent Development
Table 114. Teva Pharmaceutical Corporation Information
Table 115. Teva Pharmaceutical Description and Major Businesses
Table 116. Teva Pharmaceutical Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Teva Pharmaceutical Product
Table 118. Teva Pharmaceutical Recent Development
Table 119. Nestle Corporation Information
Table 120. Nestle Description and Major Businesses
Table 121. Nestle Gastrointestinal OTC Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 122. Nestle Product
Table 123. Nestle Recent Development
Table 124. Boehringer Ingelheim Corporation Information
Table 125. Boehringer Ingelheim Description and Major Businesses
Table 126. Boehringer Ingelheim Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 127. Boehringer Ingelheim Product
Table 128. Boehringer Ingelheim Recent Development
Table 129. Reckitt Benckiser Corporation Information
Table 130. Reckitt Benckiser Description and Major Businesses
Table 131. Reckitt Benckiser Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 132. Reckitt Benckiser Product
Table 133. Reckitt Benckiser Recent Development
Table 134. Purdue Pharma Corporation Information
Table 135. Purdue Pharma Description and Major Businesses
Table 136. Purdue Pharma Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 137. Purdue Pharma Product
Table 138. Purdue Pharma Recent Development
Table 139. Global Gastrointestinal OTC Drugs Sales Forecast by Regions (2021-2026) (K Pcs)
Table 140. Global Gastrointestinal OTC Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 141. Global Gastrointestinal OTC Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 142. Global Gastrointestinal OTC Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 143. North America: Gastrointestinal OTC Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 144. North America: Gastrointestinal OTC Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Europe: Gastrointestinal OTC Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 146. Europe: Gastrointestinal OTC Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Asia Pacific: Gastrointestinal OTC Drugs Sales Forecast by Region (2021-2026) (K Pcs)
Table 148. Asia Pacific: Gastrointestinal OTC Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 149. Latin America: Gastrointestinal OTC Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 150. Latin America: Gastrointestinal OTC Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 151. Middle East and Africa: Gastrointestinal OTC Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 152. Middle East and Africa: Gastrointestinal OTC Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 153. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 154. Key Challenges
Table 155. Market Risks
Table 156. Main Points Interviewed from Key Gastrointestinal OTC Drugs Players
Table 157. Gastrointestinal OTC Drugs Customers List
Table 158. Gastrointestinal OTC Drugs Distributors List
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Gastrointestinal OTC Drugs Product Picture
Figure 2. Global Gastrointestinal OTC Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Laxatives Product Picture
Figure 4. Anti-Flatulents Product Picture
Figure 5. H2-Antaginists Product Picture
Figure 6. Anti-Diarrheals Product Picture
Figure 7. PPIs Product Picture
Figure 8. Anti-Emetics Product Picture
Figure 9. Other Product Picture
Figure 10. Global Gastrointestinal OTC Drugs Sales Market Share by Application in 2020 & 2026
Figure 11. Hospital Pharmacies
Figure 12. Retail Pharmacies
Figure 13. Online Pharmacies
Figure 14. Gastrointestinal OTC Drugs Report Years Considered
Figure 15. Global Gastrointestinal OTC Drugs Market Size 2015-2026 (US$ Million)
Figure 16. Global Gastrointestinal OTC Drugs Sales 2015-2026 (K Pcs)
Figure 17. Global Gastrointestinal OTC Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2015-2020)
Figure 19. Global Gastrointestinal OTC Drugs Sales Market Share by Region in 2019
Figure 20. Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2015-2020)
Figure 21. Global Gastrointestinal OTC Drugs Revenue Market Share by Region in 2019
Figure 22. Global Gastrointestinal OTC Drugs Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Gastrointestinal OTC Drugs Revenue in 2019
Figure 24. Gastrointestinal OTC Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Gastrointestinal OTC Drugs Sales Market Share by Type (2015-2020)
Figure 26. Global Gastrointestinal OTC Drugs Sales Market Share by Type in 2019
Figure 27. Global Gastrointestinal OTC Drugs Revenue Market Share by Type (2015-2020)
Figure 28. Global Gastrointestinal OTC Drugs Revenue Market Share by Type in 2019
Figure 29. Global Gastrointestinal OTC Drugs Market Share by Price Range (2015-2020)
Figure 30. Global Gastrointestinal OTC Drugs Sales Market Share by Application (2015-2020)
Figure 31. Global Gastrointestinal OTC Drugs Sales Market Share by Application in 2019
Figure 32. Global Gastrointestinal OTC Drugs Revenue Market Share by Application (2015-2020)
Figure 33. Global Gastrointestinal OTC Drugs Revenue Market Share by Application in 2019
Figure 34. North America Gastrointestinal OTC Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Gastrointestinal OTC Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Gastrointestinal OTC Drugs Sales Market Share by Country in 2019
Figure 37. North America Gastrointestinal OTC Drugs Revenue Market Share by Country in 2019
Figure 38. U.S. Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Gastrointestinal OTC Drugs Market Share by Type in 2019
Figure 43. North America Gastrointestinal OTC Drugs Market Share by Application in 2019
Figure 44. Europe Gastrointestinal OTC Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Gastrointestinal OTC Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Gastrointestinal OTC Drugs Sales Market Share by Country in 2019
Figure 47. Europe Gastrointestinal OTC Drugs Revenue Market Share by Country in 2019
Figure 48. Germany Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Gastrointestinal OTC Drugs Market Share by Type in 2019
Figure 59. Europe Gastrointestinal OTC Drugs Market Share by Application in 2019
Figure 60. Asia Pacific Gastrointestinal OTC Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Gastrointestinal OTC Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Region in 2019
Figure 63. Asia Pacific Gastrointestinal OTC Drugs Revenue Market Share by Region in 2019
Figure 64. China Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Gastrointestinal OTC Drugs Market Share by Type in 2019
Figure 87. Asia Pacific Gastrointestinal OTC Drugs Market Share by Application in 2019
Figure 88. Latin America Gastrointestinal OTC Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Gastrointestinal OTC Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Gastrointestinal OTC Drugs Sales Market Share by Country in 2019
Figure 91. Latin America Gastrointestinal OTC Drugs Revenue Market Share by Country in 2019
Figure 92. Mexico Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Gastrointestinal OTC Drugs Market Share by Type in 2019
Figure 99. Latin America Gastrointestinal OTC Drugs Market Share by Application in 2019
Figure 100. Middle East and Africa Gastrointestinal OTC Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Gastrointestinal OTC Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Gastrointestinal OTC Drugs Revenue Market Share by Country in 2019
Figure 104. Turkey Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Gastrointestinal OTC Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Gastrointestinal OTC Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Gastrointestinal OTC Drugs Market Share by Type in 2019
Figure 111. Middle East and Africa Gastrointestinal OTC Drugs Market Share by Application in 2019
Figure 112. North America Gastrointestinal OTC Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America Gastrointestinal OTC Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Gastrointestinal OTC Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe Gastrointestinal OTC Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Gastrointestinal OTC Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific Gastrointestinal OTC Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Gastrointestinal OTC Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America Gastrointestinal OTC Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Gastrointestinal OTC Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa Gastrointestinal OTC Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
抗糖尿病治療薬の世界市場（～2026年） The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for…- 抗腫瘍薬の世界市場（～2026年） Tumor is also termed as neoplasm and it is caused by an abnormal proliferation of tissues. This abnormal proliferation can be due to genetic mutations. Tumors can be subcategorized as benign and malignant. Benign is not destructive however, possess a potential to turn into a malignant tumor... It ha…
- 非ステロイド性抗炎症薬（NSAID）の世界市場（～2026年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
- 胃腸装置の世界市場（～2026年） Market Analysis and Insights: Global Gastrointestinal Devices Market The global Gastrointestinal Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Gastrointestinal Devices Scope and Market Size Gastrointestinal D…
- 止瀉薬の世界市場（～2026年） Market Analysis and Insights: Global Anti Diarrheal Drugs Market The global Anti Diarrheal Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anti Diarrheal Drugs Scope and Market Size Anti Diarrheal Drugs market is…